Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy

BACKGROUND: Studies suggest that enzyme-replacement therapy (ERT) is crucial to the survival of patients with infantile-onset Pompe disease (IOPD). Hearing impairment (HI) is one of the clinical sequelae observed in long-term survivors. However, the benefits of early ERT for hearing outcomes have no...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsueh, Chien-Yu, Huang, Chii-Yuan, Yang, Chia-Feng, Chang, Chia-Chen, Lin, Wei-Sheng, Cheng, Hsiu-Lien, Wu, Shang-Liang, Cheng, Yen-Fu, Niu, Dau-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340467/
https://www.ncbi.nlm.nih.gov/pubmed/34353347
http://dx.doi.org/10.1186/s13023-021-01817-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340467/
https://www.ncbi.nlm.nih.gov/pubmed/34353347
http://dx.doi.org/10.1186/s13023-021-01817-1

Ejemplares similares